Proatherogenic changes in the quantity and quality of lipoproteins in adults with idiopathic nephrotic syndrome
Authors:
- 18 February 2025
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 570, 120206
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Sichuan Province (22NSFSC2421, 2022NSFSC0736)
This publication has 35 references indexed in Scilit:
- Nephrotic syndrome: pathophysiology and consequencesJournal Of Nephrology, 2023
- Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk PopulationsJAMA Cardiology, 2022
- Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequencesKidney International, 2016
- Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort studyAtherosclerosis, 2016
- Increased HDL Size and Enhanced Apo A‐I Catabolic Rates Are Associated With Doxorubicin‐Induced Proteinuria in New Zealand White RabbitsLipids, 2016
- HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic TargetCurrent Atherosclerosis Reports, 2015
- How Do Glucocorticoids Regulate Lipid Metabolism?2015
- Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuriaClinica Chimica Acta, 2012
- Should we measure routinely the LDL peak particle size?International Journal of Cardiology, 2006
- Lipoprotein distribution and composition in the human nephrotic syndromAtherosclerosis, 1985